A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
NCT02205307 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 347
Last updated 2020-06-24
Summary
This is a randomized, controlled, parallel, multicenter study to determine the difference in post-operative anastomotic leak rate in low anterior resection procedures where colon and rectal tissue perfusion is evaluated using PINPOINT as an adjunct to standard surgical practice compared to surgical procedures performed according to standard surgical practice alone.
Conditions
- Rectal Cancer
- Rectosigmoid Cancer
Interventions
- DEVICE
-
PINPOINT
- DEVICE
-
SPY Elite
Sponsors & Collaborators
-
Novadaq Technologies ULC, now a part of Stryker
lead INDUSTRY
Principal Investigators
-
Michael J Stamos, MD · University of California, Irvine
-
Steven Wexner, MD · Cleveland Clinic Florida
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2017-05-31
- Completion
- 2017-05-31
Countries
- United States
Study Locations
More Related Trials
-
Predicting Pathological Complete Response of Rectal Cancer With Magnetic Resonance(MR) Radiomics
NCT03238885 ·Status: COMPLETED
-
Study of High-Dose-Rate Endorectal Brachytherapy (HDRBT) in the Treatment of Locally Advanced Low Rectal Cancer
NCT01226979 ·Status: COMPLETED ·Phase: NA
-
the Efficacy of MR-guided Online Adaptive Radiotherapy for Locally Advanced Rectal Cancer
NCT07080411 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Concordance of Imaging and Pathology Diagnosis of Extranodal Tumour Deposits
NCT03303547 ·Status: RECRUITING ·Phase: NA
-
Neoadjuvant Therapy for Locally Advanced Rectal Cancer With Fruquintinib, Toripalimab and SRT
NCT05763927 ·Status: UNKNOWN ·Phase: PHASE2
-
Fluorescent Navigation Technology in Radical Resection of Pancreatic Cancer
NCT06168552 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer
NCT02151019 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
PET/MR for Staging Rectal Cancer Patients With and Without EMVI-MR
NCT02537340 ·Status: COMPLETED
-
Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery
NCT04103372 ·Status: RECRUITING ·Phase: NA
-
IMRT Versus 3DCRT for Locally Advanced Rectal Cancer, Prospective Phase II Study.
NCT06160570 ·Status: COMPLETED ·Phase: NA
-
Feasibility of Sentinel Lymph Node Biopsy in Rectal Cancer
NCT02445456 ·Status: TERMINATED ·Phase: NA
-
Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer
NCT00254683 ·Status: UNKNOWN ·Phase: PHASE2
-
Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer
NCT05524012 ·Status: ACTIVE_NOT_RECRUITING
-
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
NCT04664504 ·Status: RECRUITING ·Phase: PHASE2
-
PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery
NCT00004891 ·Status: COMPLETED ·Phase: NA
-
Ploidy and Stroma in Early Rectal Cancer
NCT03039595 ·Status: COMPLETED
-
Perfusion Outcomes With Near Infrared-Indocyanine Green Imaging System in Laparoscopic Total Mesorectal Excision for Mid- or Low-rectal CanceR
NCT04012645 ·Status: RECRUITING ·Phase: NA
-
Involve-site Radiotherapy Combined With Chemotherapy and Immunotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
NCT07161115 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Sentinel Lymph Node Mapping in Rectal Cancer
NCT02869152 ·Status: UNKNOWN ·Phase: NA
-
THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy
NCT04815694 ·Status: UNKNOWN ·Phase: NA
-
SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer
NCT06864013 ·Status: RECRUITING ·Phase: PHASE2
-
Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA
NCT00394615 ·Status: TERMINATED ·Phase: NA
-
CT Virtual Proctoscopy for Staging and Volume Assessment for Rectal Cancer
NCT00585728 ·Status: COMPLETED ·Phase: NA
-
Application of Amide Proton Transfer-Weighted Imaging in Predicting Pathological Complete Response After Neoadjuvant Therapy of Rectal Cancer
NCT06719414 ·Status: RECRUITING
-
Short-Course Radiotherapy Combined with Intracavitary Brachytherapy Followed by Pucotenlimab, Bevacizumab, Oxaliplatin, and Trifluridine/Tipiracil (TAS-102) for Total Neoadjuvant Therapy of Microsatellite Stable (MSS) Locally Advanced Low Rectal Cancer
NCT06872606 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2